Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.

MLA

Worek, Franz, et al. “Efficacy of the RePON1 Mutant IIG1 to Prevent Cyclosarin Toxicity in Vivo and to Detoxify Structurally Different Nerve Agents in Vitro.” Archives of Toxicology, vol. 88, no. 6, June 2014, pp. 1257–66. EBSCOhost, https://doi.org/10.1007/s00204-014-1204-z.

APA

Worek, F., Seeger, T., Goldsmith, M., Ashani, Y., Leader, H., Sussman, J. S., Tawfik, D., Thiermann, H., & Wille, T. (2014). Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro. Archives of Toxicology, 88(6), 1257–1266. https://doi.org/10.1007/s00204-014-1204-z

Chicago

Worek, Franz, Thomas Seeger, Moshe Goldsmith, Yacov Ashani, Haim Leader, Joel S Sussman, Dan Tawfik, Horst Thiermann, and Timo Wille. 2014. “Efficacy of the RePON1 Mutant IIG1 to Prevent Cyclosarin Toxicity in Vivo and to Detoxify Structurally Different Nerve Agents in Vitro.” Archives of Toxicology 88 (6): 1257–66. doi:10.1007/s00204-014-1204-z.